Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nepafenac vs Ketorolac and Placebo in Cataract Surgery
NCT00405730Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Nov 2005
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nepafenac in ocular inflammation, sponsored by Alcon Inc.. Started Nov 2005; status: completed.
02
Drugs
nepafenac
03
Conditions
ocular inflammation
Beyond the preview
Go deeper on NCT00405730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00405730.